Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AUPH - Aurinia Pharma Q3 2021 Earnings Preview

AUPH - Aurinia Pharma Q3 2021 Earnings Preview

Aurinia Pharmaceuticals Inc
Aurinia Pharma (NASDAQ:AUPH) is scheduled to announce Q3 earnings results on Wednesday, November 3rd, before market open. The consensus EPS Estimate is -$0.33 and the consensus Revenue Estimate is $14.15M. Aurinia shares rose 14% in reaction to posting financial results for Q2 ended June 30, 2021, in August. In September, Seeking Alpha contributor Bret Jensen noted that the company has seen a nice surge in its stock price over the past month after reporting better-than-expected initial sales for its flagship product LUPKYNIS. However, Aurinia shares fell 1.3% recently after GlaxoSmithKline denied a Mail report from Sunday that the pharma company was considering a bid. Over the last 3 months, EPS estimates have seen 1 upward revision and 6 downward. Revenue estimates have seen 1 upward revision and 5 downward. The company's shares have more than doubled year to date.

For further details see:

Aurinia Pharma Q3 2021 Earnings Preview
Stock Information
Company Name: Aurinia Pharmaceuticals Inc
Stock Symbol: AUPH
Market: NASDAQ
Website: auriniapharma.com
Menu
AUPH AUPH Quote AUPH Short AUPH News AUPH Articles AUPH Message Board
Get AUPH Alerts

News, Short Squeeze, Breakout and More Instantly...